Abstract
Background: Parkinson’s disease is a neurodegenerative disease mainly characterized by loss of dopaminergic neurons in the substantia nigra pars compacta and their terminals in the striatum. The development of neuroprotective drugs that slow or delay neurodegeneration became of a considerable interest. In numerous animal models, exogenously administered EPO exhibits neuroprotective effects. Aim: The current research investigated the impact of administration of recombinant human EPO (rhEPO) in rotenone parkinsonian rats. Materials and Methods: Thirty two adult male albino Sprague-Dawly rats were equally and randomly divided into four groups; group 1 the vehicle-treated group, group 2 rotenone-treated group, group 3 treated with rotenone in addition to intranasal rhEPO and group 4 treated with rotenone in addition to intraperitoneal rhEPO. The motor performance of the rats was evaluated. Malondialdehyde and reduced glutathione were assayed. Blood indices were measured. Histopathology of the substantia nigra was also done. Results: Results showed that rotenone-treated rats exhibited significant impairment of motor coordination and marked degeneration of substantia nigra neurons was observed. Both intranasal and intraperitoneal rhEPO treatment improved the motor deficit and significantly increased the number of neurons in the SNpc. intraperitoneal rhEPO significantly increased lipid peroxide and significantly affected blood indices. Conclusion: Our findings suggest that, EPO may have neuroprotective effect in PD. Systemic rhEPO neuroprotective effects may be attenuated by its adverse effects such as increase of OS in the vascular system and stimulation of erythropoiesis. Small doses of intranasal EPO may be sufficient to produce neuroprotection without affecting erythropoiesis and further researches are required to address the mechanisms of neuroprotective effects of EPO.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
